Convelo Therapeutics

Convelo Therapeutics

Biotechnology, Cedar Ave, Cleveland, , 44106, Ohio, 11000, United States, 1-10 Employees

convelotx.com

  • twitter
  • LinkedIn

phone no Phone Number: 21********

Who is CONVELO THERAPEUTICS

Convelo Therapeutics is developing a new class of medicines that unlock the regenerative capacity of the central nervous system. Convelo is pioneering approaches to regenerate the protect...

Read More

map
  • 11000 Cedar Ave, Cleveland, Ohio, 44106, United States Headquarters: 11000 Cedar Ave, Cleveland, Ohio, 44106, United States
  • 2016 Date Founded: 2016
  • 1-10 Employees: 1-10
  • dollar-icon Revenue: $5 Million to $10 Million
  • tech-icon Active Tech Stack: See technologies

industries-icon Industry: Biotechnology

SIC SIC Code: 2836 | NAICS Code: 541714 | Show More

checked-icon Does something look wrong? Fix it. | View contact records from CONVELO THERAPEUTICS

Convelo Therapeutics Org Chart and Mapping

Employees
signout-image
You are signed out

Sign in to CIENCE GO Data to uncover contact details

crown-icon Free credits every month

Frequently Asked Questions Regarding Convelo Therapeutics

Answer: Convelo Therapeutics's headquarters are located at Cedar Ave, Cleveland, , 44106, Ohio, 11000, United States

Answer: Convelo Therapeutics's phone number is 21********

Answer: Convelo Therapeutics's official website is https://convelotx.com

Answer: Convelo Therapeutics's revenue is $5 Million to $10 Million

Answer: Convelo Therapeutics's SIC: 2836

Answer: Convelo Therapeutics's NAICS: 541714

Answer: Convelo Therapeutics has 1-10 employees

Answer: Convelo Therapeutics is in Biotechnology

Answer: Convelo Therapeutics contact info: Phone number: 21******** Website: https://convelotx.com

Answer: Convelo Therapeutics is developing a new class of medicines that unlock the regenerative capacity of the central nervous system. Convelo is pioneering approaches to regenerate the protective myelin coating around nerve cells that is lost in a wide array of neurological diseases including multiple sclerosis, pediatric leukodystrophies, traumatic injury and age-related pathologies such as Alzheimers. Convelo has identified key biological targets and a pipeline of drug candidates to provide novel and meaningful solutions for patients and their families.

Answer:

Premium Sales Data for Prospecting

  • Sales data across over 200M records

  • Up-to-date records (less decayed data)

  • Accurate Email Lists (real-world tested)

  • Powerful search engine and intuitive interface

lock icon Get Full Access